Evidence map›Paper›PMID 42046210›Full record

ArticleBioinformatics (Oxford, England)2026

MS-ConTab: multi-scale contrastive learning of mutation signatures for Pan-Cancer representation and stratification.

Yifan Dou, Adam Khadre, Ruben C Petreaca, Mirzaei Golrokh

Erratum issuedAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yifan DouDepartment of Computer Science and Engineering, Ohio State University, Columbus, OH 43210, United States.
Adam KhadreDepartment of Computer Science and Engineering, Ohio State University, Columbus, OH 43210, United States.
Ruben C PetreacaDepartment of Molecular Genetics, Ohio State University, Marion, OH 43302, United States.
Mirzaei GolrokhDepartment of Computer Science and Engineering, Ohio State University, Columbus, OH 43210, United States.ORCID 0000-0003-1756-7604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationUnderstanding pan-cancer level mutational landscape offers critical insights into the molecular mechanisms underlying tumorigenesis. While patient-level machine learning techniques have been widely employed to identify tumor subtypes, cohort-level clustering-where entire cancer types are grouped based on shared molecular features-has largely relied on classical statistical methods.

resultsIn this study, we introduce a novel unsupervised contrastive learning framework to cluster 43 cancer types based on coding mutation data derived from the COSMIC database. For each cancer type, we construct two complementary mutation signatures: a gene-level profile capturing nucleotide substitution patterns across the most frequently mutated genes, and a chromosome-level profile representing normalized substitution frequencies across chromosomes. These dual views are encoded using TabNet encoders and optimized via a multi-scale contrastive learning objective (NT-Xent loss) to learn unified cancer-type embeddings. We demonstrate that the resulting latent representations yield biologically meaningful clusters of cancer types, aligning with known mutational processes and tissue origins. Our work represents the first application of contrastive learning to cohort-level cancer clustering, offering a scalable and interpretable framework for mutation-driven cancer subtyping. AVAILABILITY AND IMPLEMENTATION: Data and Code are available at: https://github.com/25Nov/MS-ConTab. SUPPLEMENTARY INFORMATION: Supplementary material includes Supplementary Table 1-3 and Supplementary Figure 1, which provide additional data supporting the main results.

Indexed as

Computational BiologyMachine LearningMutationNeoplasmsSoftwareCluster AnalysisClustering AlgorithmsDatabases, GeneticHumans

Identifiers

PMID42046210
PMCPMC13139774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.